首页> 外国专利> New bicyclic benzene derivatives useful as factor Xa and VIIa inhibitors, e.g. for treating thrombosis, myocardial infarct, arteriosclerosis, inflammation, stroke, angina, restenosis and tumors

New bicyclic benzene derivatives useful as factor Xa and VIIa inhibitors, e.g. for treating thrombosis, myocardial infarct, arteriosclerosis, inflammation, stroke, angina, restenosis and tumors

机译:可用作因子Xa和VIIa抑制剂的新双环苯衍生物,例如用于治疗血栓形成,心肌梗塞,动脉硬化,炎症,中风,心绞痛,再狭窄和肿瘤

摘要

Bicyclic benzene derivatives (I) are new. Bicyclic benzene derivatives of formula (I) and their derivatives, solvates and stereoisomers are new. D = (un)saturated 3-4C alkylene, optionally by 1-3 C atoms replaced by heteroatoms (by 1-3 N, 1-2 O and/or 1-2 S) and optionally substituted by 1-3 halo, A, (C(R)2)nQ, OR', N(R')2, NO2, CN, COOR', CON(R')2, NR'COA, NR'SO2A, COR', SO2NR' and SOmA and optionally with one CH2 group replaced by CO; R1 = H, halo, A, OR', N(R')2, CN, COOR', CON(R')2 or (C(R)2)nQ; R' = H, A or (C(R)2)nQ; R = H or A; Q = Ar, Het or cycloalkyl; W = C(R')2, (C(R')2)2, OC(R')2 or NR'C(R')2; X = CONR', CONR'CR2, C(R)2NR' or C(R)2NR'C(R)2; Y = alkylene, cycloalkylene, Het-diyl or Ar-diyl; T = mono- or bicyclic heterocyclyl with 1-4 N, O and/or S atoms and substituted by 1-3 oxo groups and 0-3 halo, A, (C(R)2)nQ, OR', N(R')2, NO2, CN, COOR', CON(R')2, NR'COA, NR'SO2A, COR', SO2NR' and SOmA; A = 1-6C alkyl in which 1-2 CH2 groups can be replaced by O, S and/or CH=CH and 1-7 H atoms can be replaced by F; Ar = phenyl, naphthyl or biphenylyl optionally substituted by 1-3 halo, A, OR', N(R')2, NO2, CN, COOR', CON(R')2, NR'COA, NR'SO2A, COR', SO2NR' and SOmA; Het = mono- or bicyclic heterocyclyl with 1-4 N, O and/or S atoms optionally substituted by 1-3 oxo, halo, A, (C(R)2)nQ', OR', NR'2, NO2, CN, COOR', CON(R')2, NR'COA, NR'SO2A, COR', SO2NR' and SOmA; Q' = Ar, Het' or cycloalkyl; Het' = mono- or bicyclic heterocyclyl with 1-2 N, O and/or S atoms optionally substituted by 1-2 oxo, halo, A, OR', N(R')2, NO2, CN, COOR', CON(R')2, NR'COA, NR'SO2A, COR', SO2NR' and SOmA; and n, m = 0-2. Independent claims are also included for: (1) preparation of (I); (2) a kit comprising a compound (I) and another drug in separate packs; and (3) intermediates of formula (VI). R'' = H or Me; and n' = 3-5.
机译:双环苯衍生物(Ⅰ)是新的。式(I)的双环苯衍生物及其衍生物,溶剂化物和立体异构体是新的。 D =(不)饱和的3-4C亚烷基,可选地被被杂原子(被1-3 N,1-2 O和/或1-2 S取代)并被1-3卤素取代的1-3 C原子,(C(R)2)nQ,OR',N(R')2,NO2,CN,COOR',CON(R')2,NR'COA,NR'SO2A,COR',SO2NR'和SOmA任选地,一个CH 2基团被CO取代; R1 = H,卤素,A,OR',N(R')2,CN,COOR',CON(R')2或(C(R)2)nQ; R'= H,A或(C(R)2)nQ; R = H或A; Q = Ar,Het或环烷基; W = C(R')2,(C(R')2)2,OC(R')2或NR'C(R')2; X = CONR',CONR'CR2,C(R)2NR'或C(R)2NR'C(R)2; Y =亚烷基,亚环烷基,Het-二基或Ar-二基; T =具有1-4个N,O和/或S原子并被1-3个氧代基团和0-3个卤素取代的单环或双环杂环基,A,(C(R)2)nQ,OR',N(R ')2,NO2,CN,COOR',CON(R')2,NR'COA,NR'SO2A,COR',SO2NR'和SOmA; A = 1-6C烷基,其中1-2个CH 2基团可以被O,S和/或CH = CH取代,并且1-7个H原子可以被F取代; Ar =任选被1-3个卤素,A,OR',N(R')2,NO2,CN,COOR',CON(R')2,NR'COA,NR'SO2A,COR取代的苯基,萘基或联苯基',SO2NR'和SOmA; Het =具有1-4个N,O和/或S原子的单环或双环杂环基,可任选被1-3个氧代,卤素,A,(C(R)2)nQ',OR',NR'2,NO2, CN,COOR',CON(R')2,NR'COA,NR'SO2A,COR',SO2NR'和SOmA; Q'= Ar,Het'或环烷基; Het'=具有1-2个N,O和/或S原子的单环或双环杂环基,可选地被1-2个氧代,卤素,A,OR',N(R')2,NO2,CN,COOR',CON取代(R')2,NR'COA,NR'SO2A,COR',SO2NR'和SOmA;并且n,m = 0-2。还包括以下方面的独立权利要求:(1)(I)的制备; (2)试剂盒,其在单独包装中包含化合物(I)和另一种药物; (3)式(VI)的中间体。 R''= H或我;并且n'= 3-5。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号